Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition (Q33700887)

28 July 2017

1 reference

title

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition (English)

1 reference

28 July 2017

0 references

0 references

0 references

Marco Colizzi

1

0 references

Sagnik Bhattacharyya

object named as

Sagnik Bhattacharyya

series ordinal

2

0 references

language of work or name

1 reference

29 April 2017

1 reference

Current addiction reports

28 July 2017

1 reference

28 July 2017

4

1 reference

28 July 2017

62-74

1 reference

28 July 2017

2

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

start time

29 April 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s40429-017-0142-2

0 references

cites work

A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case-control study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Substance use, medication adherence and outcome one year following a first episode of psychosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Gone to Pot - A Review of the Association between Cannabis and Psychosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Does Cannabidiol Protect Against Adverse Psychological Effects of THC?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Acute and non-acute effects of cannabis on human memory function: a critical review of neuroimaging studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Persistent cannabis users show neuropsychological decline from childhood to midlife

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Neural mechanisms for the cannabinoid modulation of cognition and affect in man: a critical review of neuroimaging studies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Increasing delta-9-tetrahydrocannabinol (Δ-9-THC) content in herbal cannabis over time: systematic review and meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Cannabis, the mind and society: the hash realities

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

The acute effects of cannabinoids on memory in humans: a review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Cognitive functioning of long-term heavy cannabis users seeking treatment.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Adverse effects of cannabis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Recent Advances in the Chemistry of Hashish

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Pharmacological characterization of cannabinoids in the elevated plus maze

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Antianxiety effect of cannabidiol in the elevated plus-maze

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Effects of Marijuana Extract Distillate and Cannabidiol on Variable Interval Performance as a Function of Food Deprivation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5435777

Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study.

28 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Modulation of mediotemporal and ventrostriatal function in humans by Delta9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

The effects of cannabis on memory function in users with and without a psychotic disorder: findings from a combined meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Neuropsychological performance in long-term cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

The role of cannabis in cognitive functioning of patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Working memory performance in young adults is associated to the AATn polymorphism of the CNR1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Functional genetic variation of the cannabinoid receptor 1 and cannabis use interact on prefrontal connectivity and related working memory behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Interaction Between Functional Genetic Variation of DRD2 and Cannabis Use on Risk of Psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Non-acute (residual) neurocognitive effects of cannabis use: a meta-analytic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Effects of frequent cannabis use on hippocampal activity during an associative memory task.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Effects of Δ9-tetrahydrocannabinol administration on human encoding and recall memory function: a pharmacological FMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Perinatal exposure to delta-9-tetrahydrocannabinol causes enduring cognitive deficits associated with alteration of cortical gene expression and neurotransmission in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Cannabinoid modulation of functional connectivity within regions processing attentional salience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Performance of schizophrenic patients in the Stroop Color Word Test and electrodermal responsiveness after acute administration of cannabidiol (CBD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

The residual cognitive effects of heavy marijuana use in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Abnormal brain activity in prefrontal brain regions in abstinent marijuana users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Continuity of cannabis use and violent offending over the life course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40429-017-0142-2

Cannabis, cognition, and residual confounding

21 January 2018

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

1 reference

12 December 2020

Effects of ipsapirone and cannabidiol on human experimental anxiety

1 reference

12 December 2020

Chemical basis of hashish activity

1 reference

12 December 2020

10.1007/S40429-017-0142-2

Identifiers

DOI

1 reference

PubMed ID

28580227

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference

PubMed ID

28580227